Mazama Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-2,221
| Closed | -$49K | – | 52 |
|
|
2015
Q4 | $49K | Buy |
2,221
+880
| +66% | +$19.4K | 0.01% | 214 |
|
|
2015
Q3 | $32K | Buy |
+1,341
| New | +$32K | 0.01% | 226 |
|
|
2015
Q2 | – | Sell |
-202
| Closed | -$19K | – | 292 |
|
|
2015
Q1 | $19K | Sell |
202
-528
| -72% | -$49.7K | ﹤0.01% | 256 |
|
|
2014
Q4 | $30K | Sell |
730
-2,542
| -78% | -$104K | 0.01% | 248 |
|
|
2014
Q3 | $80K | Buy |
3,272
+1,993
| +156% | +$48.7K | 0.02% | 206 |
|
|
2014
Q2 | $20K | Hold |
1,279
| – | – | 0.01% | 251 |
|
|
2014
Q1 | $19K | Sell |
1,279
-50,638
| -98% | -$752K | 0.02% | 218 |
|
|
2013
Q4 | $713K | Sell |
51,917
-50,707
| -49% | -$696K | 0.35% | 114 |
|
|
2013
Q3 | $1.94M | Sell |
102,624
-48,998
| -32% | -$924K | 1.06% | 27 |
|
|
2013
Q2 | $2.14M | Buy |
+151,622
| New | +$2.14M | 1.33% | 19 |
|